Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

METRO1: A Phase I Study of Metronomic Chemotherapy in Adults with Advanced Refractory Solid Tumors.

Launay S, Sabatier R, Brunelle S, Esterni B, Tarpin C, Viret F, Gravis G, Cappiello M, Provansal M, Extra JM, Bertucci F, Viens P, Goncalves A.

Anticancer Res. 2016 Jan;36(1):293-9.

PMID:
26722056
2.

Azacitidine treatment for patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 3q abnormalities.

Wanquet A, Prebet T, Berthon C, Sebert M, Roux C, Kulasekararaj A, Micol JB, Esterni B, Itzykson R, Thepot S, Recher C, Delaunay J, Dreyfus F, Mufti G, Fenaux P, Vey N.

Am J Hematol. 2015 Oct;90(10):859-63. doi: 10.1002/ajh.24099. Epub 2015 Jul 14.

3.

Reduced-toxicity conditioning prior to allogeneic stem cell transplantation improves outcome in patients with myeloid malignancies.

Oudin C, Chevallier P, Furst S, Guillaume T, El Cheikh J, Delaunay J, Castagna L, Faucher C, Granata A, Devillier R, Chabannon C, Esterni B, Vey N, Mohty M, Blaise D.

Haematologica. 2014 Nov;99(11):1762-8. doi: 10.3324/haematol.2014.105981. Epub 2014 Aug 1.

4.

Reduced-intensity conditioning regimen with in vivo T-cell depletion for patients with haematological malignancies: results using unrelated and sibling donors.

Castagna L, Crocchiolo R, Furst S, El-cheikh J, Esterni B, Granata A, Stoppa A, Boubdallah R, Coso D, Vey N, Charbonnier A, Lemarie C, Faucher C, Chabannon C, Blaise D.

Bone Marrow Transplant. 2014 Sep;49(9):1246-7. doi: 10.1038/bmt.2014.138. Epub 2014 Jul 7. No abstract available. Erratum in: Bone Marrow Transplant. 2014 Sep;49(9):1248.

PMID:
25000454
5.

Prognostic value of isolated tumor cells and micrometastases of lymph nodes in early-stage breast cancer: a French sentinel node multicenter cohort study.

Houvenaeghel G, Classe JM, Garbay JR, Giard S, Cohen M, Faure C, Hélène C, Belichard C, Uzan S, Hudry D, Azuar P, Villet R, Penault Llorca F, Tunon de Lara C, Goncalves A, Esterni B; et al.

Breast. 2014 Oct;23(5):561-6. doi: 10.1016/j.breast.2014.04.004. Epub 2014 May 27.

6.

Efficacy and safety of lenalinomide combined with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma.

Ivanov V, Coso D, Chetaille B, Esterni B, Olive D, Aurran-Schleinitz T, Schiano JM, Stoppa AM, Broussais-Guillaumot F, Blaise D, Bouabdallah R.

Leuk Lymphoma. 2014 Nov;55(11):2508-13. doi: 10.3109/10428194.2014.889822. Epub 2014 Mar 17.

PMID:
24506467
7.

Patients' self-assessment versus investigators' evaluation in a phase III trial in non-castrate metastatic prostate cancer (GETUG-AFU 15).

Gravis G, Marino P, Joly F, Oudard S, Priou F, Esterni B, Latorzeff I, Delva R, Krakowski I, Laguerre B, Rolland F, Théodore C, Deplanque G, Ferrero JM, Pouessel D, Mourey L, Beuzeboc P, Zanetta S, Habibian M, Berdah JF, Dauba J, Baciuchka M, Platini C, Linassier C, Labourey JL, Machiels JP, El Kouri C, Ravaud A, Suc E, Eymard JC, Hasbini A, Bousquet G, Soulie M, Fizazi K.

Eur J Cancer. 2014 Mar;50(5):953-62. doi: 10.1016/j.ejca.2013.11.034. Epub 2014 Jan 11.

PMID:
24424105
8.

Characteristics and clinical outcome of T1 breast cancer: a multicenter retrospective cohort study.

Houvenaeghel G, Goncalves A, Classe JM, Garbay JR, Giard S, Charytensky H, Cohen M, Belichard C, Faure C, Uzan S, Hudry D, Azuar P, Villet R, Gimbergues P, Tunon de Lara C, Martino M, Lambaudie E, Coutant C, Dravet F, Chauvet MP, Chéreau Ewald E, Penault-Llorca F, Esterni B.

Ann Oncol. 2014 Mar;25(3):623-8. doi: 10.1093/annonc/mdt532. Epub 2014 Jan 7.

9.

Assessment of prognostic scores in brain metastases from breast cancer.

Tabouret E, Metellus P, Gonçalves A, Esterni B, Charaffe-Jauffret E, Viens P, Tallet A.

Neuro Oncol. 2014 Mar;16(3):421-8. doi: 10.1093/neuonc/not200. Epub 2013 Dec 4.

10.

Large B-cell lymphomas in adolescents and young adults in comparison to adult patients: a matched-control analysis in 55 patients.

Coso D, Garciaz S, Esterni B, Broussais-Guillaumot F, Ivanov V, Aurran-Schleinitz T, Schiano JM, Stoppa AM, Chetaille B, Blaise D, Vey N, Bouabdallah R.

Leuk Lymphoma. 2014 Aug;55(8):1849-53. doi: 10.3109/10428194.2013.858814. Epub 2014 Feb 14.

PMID:
24160849
11.

Reassessment of scoring systems and prognostic factors for metastatic spinal cord compression.

Tabouret E, Cauvin C, Fuentes S, Esterni B, Adetchessi T, Salem N, Madroszyk A, Gonçalves A, Casalonga F, Gravis G.

Spine J. 2015 May 1;15(5):944-50. doi: 10.1016/j.spinee.2013.06.036. Epub 2013 Oct 9.

PMID:
24120144
12.

SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 cases.

Jacquemier J, Spyratos F, Esterni B, Mozziconacci MJ, Antoine M, Arnould L, Lizard S, Bertheau P, Lehmann-Che J, Fournier CB, Krieger S, Bibeau F, Lamy PJ, Chenard MP, Legrain M, Guinebretière JM, Loussouarn D, Macgrogan G, Hostein I, Mathieu MC, Lacroix L, Valent A, Robin YM, Revillion F, Triki ML, Seaume A, Salomon AV, de Cremoux P, Portefaix G, Xerri L, Vacher S, Bièche I, Penault-Llorca F.

BMC Cancer. 2013 Jul 22;13:351. doi: 10.1186/1471-2407-13-351.

13.

Endomicroscopy in bile duct: Inflammation interferes with pCLE applied in the bile duct: A prospective study of 54 patients.

Caillol F, Bories E, Poizat F, Pesenti C, Esterni B, Monges G, Giovannini M.

United European Gastroenterol J. 2013 Apr;1(2):120-7. doi: 10.1177/2050640613483462.

14.

Peripheral T-cell lymphomas: analysis of histology, staging and response to treatment of 208 cases at a single institution.

Broussais-Guillaumot F, Coso D, Belmecheri N, Ivanov V, Schiano de Collela JM, Aurran-Schleinitz T, Stoppa AM, Chetaille B, Xerri L, Esterni B, Blaise D, Bouabdallah R.

Leuk Lymphoma. 2013 Nov;54(11):2392-8. doi: 10.3109/10428194.2013.776680. Epub 2013 Mar 27.

PMID:
23410100
15.

Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial.

Gravis G, Fizazi K, Joly F, Oudard S, Priou F, Esterni B, Latorzeff I, Delva R, Krakowski I, Laguerre B, Rolland F, Théodore C, Deplanque G, Ferrero JM, Pouessel D, Mourey L, Beuzeboc P, Zanetta S, Habibian M, Berdah JF, Dauba J, Baciuchka M, Platini C, Linassier C, Labourey JL, Machiels JP, El Kouri C, Ravaud A, Suc E, Eymard JC, Hasbini A, Bousquet G, Soulie M.

Lancet Oncol. 2013 Feb;14(2):149-58. doi: 10.1016/S1470-2045(12)70560-0. Epub 2013 Jan 8.

PMID:
23306100
16.

Two days of antithymocyte globulin are associated with a reduced incidence of acute and chronic graft-versus-host disease in reduced-intensity conditioning transplantation for hematologic diseases.

Crocchiolo R, Esterni B, Castagna L, Fürst S, El-Cheikh J, Devillier R, Granata A, Oudin C, Calmels B, Chabannon C, Bouabdallah R, Vey N, Blaise D.

Cancer. 2013 Mar 1;119(5):986-92. doi: 10.1002/cncr.27858. Epub 2012 Oct 23.

17.

BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer.

Gonçalves A, Gilabert M, François E, Dahan L, Perrier H, Lamy R, Re D, Largillier R, Gasmi M, Tchiknavorian X, Esterni B, Genre D, Moureau-Zabotto L, Giovannini M, Seitz JF, Delpero JR, Turrini O, Viens P, Raoul JL.

Ann Oncol. 2012 Nov;23(11):2799-805. doi: 10.1093/annonc/mds135. Epub 2012 Jul 5.

18.

Poor autologous mobilization status does not impact on hematological recovery but affects outcome after allogeneic stem cell transplant for lymphoma and myeloma.

Crocchiolo R, Chabannon C, El-Cheikh J, Esterni B, Lemarié C, Fürst S, Castagna L, Bouabdallah R, Ladaique P, Coso D, Schiano JM, Stoppa AM, Rey J, Ivanov V, Aurran T, Faucher C, Blaise D, Calmels B.

Leuk Lymphoma. 2013 Feb;54(2):417-20. doi: 10.3109/10428194.2012.702901. Epub 2012 Jul 9. No abstract available.

PMID:
22702654
19.

Outcome of acute myeloid leukaemia following myelodysplastic syndrome after azacitidine treatment failure.

Prébet T, Gore SD, Thépot S, Esterni B, Quesnel B, Beyne Rauzy O, Dreyfus F, Gardin C, Fenaux P, Vey N.

Br J Haematol. 2012 Jun;157(6):764-6. doi: 10.1111/j.1365-2141.2012.09076.x. Epub 2012 Mar 6. No abstract available.

20.

Radiofrequency ablation associated to mucosal resection in the oesophagus: experience in a single centre.

Caillol F, Bories E, Pesenti C, Poizat F, Monges G, Guiramand J, Esterni B, Giovannini M.

Clin Res Hepatol Gastroenterol. 2012 Aug;36(4):371-7. doi: 10.1016/j.clinre.2012.01.004. Epub 2012 Feb 21.

PMID:
22361442
21.

The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT.

Devillier R, Crocchiolo R, Castagna L, Fürst S, El Cheikh J, Faucher C, Prebet T, Etienne A, Chabannon C, Vey N, Esterni B, Blaise D.

Bone Marrow Transplant. 2012 May;47(5):639-45. doi: 10.1038/bmt.2012.3. Epub 2012 Feb 6.

PMID:
22307016
22.

Critically ill cancer patients in the intensive care unit: short-term outcome and 1-year mortality.

Mokart D, Etienne A, Esterni B, Brun JP, Chow-Chine L, Sannini A, Faucher M, Blache JL.

Acta Anaesthesiol Scand. 2012 Feb;56(2):178-89. doi: 10.1111/j.1399-6576.2011.02579.x. Epub 2011 Dec 12.

PMID:
22150473
23.

Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC-PACS 01 randomized trial.

Jacquemier J, Boher JM, Roche H, Esterni B, Serin D, Kerbrat P, Andre F, Finetti P, Charafe-Jauffret E, Martin AL, Campone M, Viens P, Birnbaum D, Penault-Llorca F, Bertucci F.

Breast Cancer Res. 2011;13(6):R109. doi: 10.1186/bcr3051. Epub 2011 Nov 1.

24.

Non sentinel node involvement prediction for sentinel node micrometastases in breast cancer: nomogram validation and comparison with other models.

Houvenaeghel G, Bannier M, Nos C, Giard S, Mignotte H, Jacquemier J, Martino M, Esterni B, Belichard C, Classe JM, Tunon de Lara C, Cohen M, Payan R, Blanchot J, Rouanet P, Penault-Llorca F, Bonnier P, Fournet S, Agostini A, Marchal F, Garbay JR.

Breast. 2012 Apr;21(2):204-9. doi: 10.1016/j.breast.2011.09.013. Epub 2011 Oct 19.

25.

Outcome of high-risk myelodysplastic syndrome after azacitidine treatment failure.

Prébet T, Gore SD, Esterni B, Gardin C, Itzykson R, Thepot S, Dreyfus F, Rauzy OB, Recher C, Adès L, Quesnel B, Beach CL, Fenaux P, Vey N.

J Clin Oncol. 2011 Aug 20;29(24):3322-7. doi: 10.1200/JCO.2011.35.8135. Epub 2011 Jul 25.

26.

Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs.

Faucher C, Le Corroller Soriano AG, Esterni B, Vey N, Stoppa AM, Chabannon C, Mohty M, Michallet M, Bay JO, Genre D, Maraninchi D, Viens P, Moatti JP, Blaise D.

Bone Marrow Transplant. 2012 Apr;47(4):549-55. doi: 10.1038/bmt.2011.126. Epub 2011 Jul 4.

PMID:
21725375
27.

[Predictive factors of tumour response after neoadjuvant chemoradiation for locally advanced rectal cancer and correlation of these factors with survival].

Farnault B, Moureau-Zabotto L, de Chaisemartin C, Esterni B, Lelong B, Viret F, Giovannini M, Monges G, Delpero JR, Bories E, Turrini O, Viens P, Resbeut M.

Cancer Radiother. 2011 Jul;15(4):279-86. doi: 10.1016/j.canrad.2011.01.005. Epub 2011 Apr 22. French.

PMID:
21515083
28.

Capecitabine after anthracycline and taxane exposure in HER2-negative metastatic breast cancer patients: response, survival and prognostic factors.

Gilabert M, Bertucci F, Esterni B, Madroszyk A, Tarpin C, Jacquemier J, Extra JM, Viens P, Gonçalves A.

Anticancer Res. 2011 Mar;31(3):1079-86.

PMID:
21498742
29.

Peritumoural vascular invasion: a major determinant of triple-negative breast cancer outcome.

Sabatier R, Jacquemier J, Bertucci F, Esterni B, Finetti P, Azario F, Birnbaum D, Viens P, Gonçalves A, Extra JM.

Eur J Cancer. 2011 Jul;47(10):1537-45. doi: 10.1016/j.ejca.2011.02.002. Epub 2011 Mar 8.

PMID:
21392964
30.

High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinoma.

Jacquemier J, Bertucci F, Finetti P, Esterni B, Charafe-Jauffret E, Thibult ML, Houvenaeghel G, Van den Eynde B, Birnbaum D, Olive D, Xerri L.

Int J Cancer. 2012 Jan 1;130(1):96-104. doi: 10.1002/ijc.25979.

31.

Once-weekly liposomal amphotericin B for prophylaxis of invasive fungal infection after graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: a comparative retrospective single-center study.

El Cheikh J, Castagna L, Wang L, Esterni B, Faucher C, Furst S, Duran S, Berger P, Ranque S, Mohty M, Blaise D.

Hematol Oncol Stem Cell Ther. 2010;3(4):167-73.

32.

Predictive factors of tumor response after neoadjuvant chemoradiation for locally advanced rectal cancer.

Moureau-Zabotto L, Farnault B, de Chaisemartin C, Esterni B, Lelong B, Viret F, Giovannini M, Monges G, Delpero JR, Bories E, Turrini O, Viens P, Salem N.

Int J Radiat Oncol Biol Phys. 2011 Jun 1;80(2):483-91. doi: 10.1016/j.ijrobp.2010.02.025. Epub 2010 Nov 18.

PMID:
21093174
33.

Improved outcome of patients with low- and intermediate-risk cytogenetics acute myeloid leukemia (AML) in first relapse with gemtuzumab and cytarabine versus cytarabine: results of a retrospective comparative study.

Prebet T, Etienne A, Devillier R, Romeo E, Charbonnier A, D'incan E, Esterni B, Arnoulet C, Blaise D, Vey N.

Cancer. 2011 Mar 1;117(5):974-81. doi: 10.1002/cncr.25554. Epub 2010 Oct 18.

34.

Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCT.

Castagna L, Fürst S, Marchetti N, El Cheikh J, Faucher C, Mohty M, Bouabdallah R, Vey N, Stoppa AM, Esterni B, Blaise D.

Bone Marrow Transplant. 2011 Jul;46(7):1000-5. doi: 10.1038/bmt.2010.227. Epub 2010 Oct 4.

PMID:
20921945
35.

ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.

Gelsi-Boyer V, Trouplin V, Roquain J, Adélaïde J, Carbuccia N, Esterni B, Finetti P, Murati A, Arnoulet C, Zerazhi H, Fezoui H, Tadrist Z, Nezri M, Chaffanet M, Mozziconacci MJ, Vey N, Birnbaum D.

Br J Haematol. 2010 Nov;151(4):365-75. doi: 10.1111/j.1365-2141.2010.08381.x. Epub 2010 Sep 29.

PMID:
20880116
36.

Reduced-intensity conditioning with Fludarabin, oral Busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignancies.

Blaise D, Farnault L, Faucher C, Marchetti N, Fürst S, El Cheikh J, Ladaique P, Vey N, Bouabdallah R, Stoppa AM, Lemarie C, Calmels B, Prebet T, Castagna L, Chabannon C, Mohty M, Esterni B.

Exp Hematol. 2010 Dec;38(12):1241-50. doi: 10.1016/j.exphem.2010.08.012. Epub 2010 Sep 17.

PMID:
20850502
37.

Impact of prior invasive aspergillosis on outcome in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplant.

El-Cheikh J, Castagna L, Wang L, Esterni B, Faucher C, Fürst S, Pierre B, Mohty M, Blaise D.

Leuk Lymphoma. 2010 Sep;51(9):1705-10. doi: 10.3109/10428194.2010.500433.

PMID:
20629522
38.

Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer.

Bertucci F, Borie N, Roche H, Bachelot T, Le Doussal JM, Macgrogan G, Debono S, Martinec A, Treilleux I, Finetti P, Esterni B, Extra JM, Geneve J, Hermitte F, Chabannon C, Jacquemier J, Martin AL, Longy M, Maraninchi D, Fert V, Birnbaum D, Viens P.

Breast Cancer Res Treat. 2011 Jun;127(2):363-73. doi: 10.1007/s10549-010-1003-z. Epub 2010 Jun 29.

PMID:
20585850
39.

The cell polarity PTK7 receptor acts as a modulator of the chemotherapeutic response in acute myeloid leukemia and impairs clinical outcome.

Prebet T, Lhoumeau AC, Arnoulet C, Aulas A, Marchetto S, Audebert S, Puppo F, Chabannon C, Sainty D, Santoni MJ, Sebbagh M, Summerour V, Huon Y, Shin WS, Lee ST, Esterni B, Vey N, Borg JP.

Blood. 2010 Sep 30;116(13):2315-23. doi: 10.1182/blood-2010-01-262352. Epub 2010 Jun 17.

PMID:
20558616
40.

A gene expression signature identifies two prognostic subgroups of basal breast cancer.

Sabatier R, Finetti P, Cervera N, Lambaudie E, Esterni B, Mamessier E, Tallet A, Chabannon C, Extra JM, Jacquemier J, Viens P, Birnbaum D, Bertucci F.

Breast Cancer Res Treat. 2011 Apr;126(2):407-20. doi: 10.1007/s10549-010-0897-9. Epub 2010 May 21.

41.

Impact of an all-oral capecitabine and vinorelbine combination regimen on functional status of elderly patients with advanced solid tumours: A multicentre pilot study of the French geriatric oncology group (GERICO).

Rousseau F, Retornaz F, Joly F, Esterni B, Abadie-Lacourtoisie S, Fargeot P, Luporsi E, Servent V, Laguerre B, Brain E, Geneve J; Programme d’Action Concertée GERIatrie onCOlogie (PAC GERICO).

Crit Rev Oncol Hematol. 2010 Oct;76(1):71-8. doi: 10.1016/j.critrevonc.2009.12.003. Epub 2010 Mar 30.

PMID:
20356760
42.

The learning curve for the laparoscopic approach to conservative mesorectal excision for rectal cancer: lessons drawn from a single institution's experience.

Bege T, Lelong B, Esterni B, Turrini O, Guiramand J, Francon D, Mokart D, Houvenaeghel G, Giovannini M, Delpero JR.

Ann Surg. 2010 Feb;251(2):249-53. doi: 10.1097/SLA.0b013e3181b7fdb0.

PMID:
20040854
43.

Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.

Charafe-Jauffret E, Ginestier C, Iovino F, Tarpin C, Diebel M, Esterni B, Houvenaeghel G, Extra JM, Bertucci F, Jacquemier J, Xerri L, Dontu G, Stassi G, Xiao Y, Barsky SH, Birnbaum D, Viens P, Wicha MS.

Clin Cancer Res. 2010 Jan 1;16(1):45-55. doi: 10.1158/1078-0432.CCR-09-1630. Epub 2009 Dec 22.

44.

Docetaxel first-line therapy in HER2-negative advanced breast cancer: a cohort study in patients with prospectively determined HER2 status.

Gonçalves A, Deblock M, Esterni B, Tarpin C, Bertucci F, Gilabert M, Charafe-Jauffret E, Jacquemier J, Houvenaeghel G, Extra JM, Viens P.

Anticancer Drugs. 2009 Nov;20(10):946-52. doi: 10.1097/CAD.0b013e328331178f.

PMID:
19741502
45.

Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup.

Prébet T, Boissel N, Reutenauer S, Thomas X, Delaunay J, Cahn JY, Pigneux A, Quesnel B, Witz F, Thépot S, Ugo V, Terre C, Recher C, Tavernier E, Hunault M, Esterni B, Castaigne S, Guilhot F, Dombret H, Vey N; Acute Leukemia French Association; Groupe Ouest-Est des leucémies et autres maladies du sang (GOELAMS); Core Binding Factor Acute Myeloid Leukemia (CBF AML) intergroup.

J Clin Oncol. 2009 Oct 1;27(28):4747-53. doi: 10.1200/JCO.2008.21.0674. Epub 2009 Aug 31.

PMID:
19720919
46.

Resection of residual masses after chemotherapy for advanced non-seminomatous germ cell tumours, a monocentric analysis of pre-operative prognosticators.

Deville JL, Gravis G, Salem N, Savoie PH, Esterni B, Walz J, Thomas P, Goncalves A, Viens P, Bladou F.

Eur J Cancer Care (Engl). 2010 Nov;19(6):827-32. doi: 10.1111/j.1365-2354.2009.01123.x.

PMID:
19708949
47.

Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer.

Jacquemier J, Charafe-Jauffret E, Monville F, Esterni B, Extra JM, Houvenaeghel G, Xerri L, Bertucci F, Birnbaum D.

Breast Cancer Res. 2009;11(2):R23. doi: 10.1186/bcr2249. Epub 2009 Apr 30.

48.

CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.

Zabouo G, Imbert AM, Jacquemier J, Finetti P, Moreau T, Esterni B, Birnbaum D, Bertucci F, Chabannon C.

Breast Cancer Res. 2009;11(1):R1. doi: 10.1186/bcr2215. Epub 2009 Jan 5.

49.

Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome.

Chetaille B, Bertucci F, Finetti P, Esterni B, Stamatoullas A, Picquenot JM, Copin MC, Morschhauser F, Casasnovas O, Petrella T, Molina T, Vekhoff A, Feugier P, Bouabdallah R, Birnbaum D, Olive D, Xerri L.

Blood. 2009 Mar 19;113(12):2765-3775. doi: 10.1182/blood-2008-07-168096. Epub 2008 Dec 18.

PMID:
19096012
50.

A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis.

Houvenaeghel G, Nos C, Giard S, Mignotte H, Esterni B, Jacquemier J, Buttarelli M, Classe JM, Cohen M, Rouanet P, Penault Llorca F, Bonnier P, Marchal F, Garbay JR, Fraisse J, Martel P, Fondrinier E, Tunon de Lara C, Rodier JF.

Eur J Surg Oncol. 2009 Jul;35(7):690-5. doi: 10.1016/j.ejso.2008.10.003. Epub 2008 Nov 28.

PMID:
19046847

Supplemental Content

Loading ...
Support Center